Robert Blaustein - Chief Development Officer at Edgewise Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Stock Symbol
EWTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert Blaustein since 11/28/2024

Holdings reported by Robert Blaustein for Edgewise Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 17.5K $821K $27.37 Aug 12, 2025 Direct Common Stock
Stock Options (Right to buy) 105K Aug 12, 2025 Direct Common Stock

Transactions reported by Robert Blaustein for Edgewise Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.